BDX vs BAX — Key Metrics
| Metric | BDX (BECTON DICKINSON & CO) | BAX (BAXTER INTERNATIONAL INC) |
|---|---|---|
| Price | 216.08 | 26.16 |
| Market Cap | 58.86 Billion | 13.53 Billion |
| P/E (TTM) | 65.08 | -18.42 |
| P/B (Quarterly) | 1.975 | 1.87 |
| P/S (TTM) | 2.82 | 1.17 |
| Net Profit Margin (TTM) | 4.5 | -6.2 |
| Gross Margin (TTM) | 46.4 | 30.1 |
| ROE (TTM) | 3.8 | -11.6 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Outperform
Recommendation Summary
BDX is not scored by the AI model, which covers non-financial S&P 500 companies (banks, insurers and asset managers report on a different basis), so there is no recommendation for this pair.
Financial Metrics
| BDX | Metrics | BAX |
|---|---|---|
| $216.08 | Price | $26.16 |
| — | Market Capitalization | — |
| 2.82 | Price to Sales | 1.17 |
| 23.25 | Price to FCF Ratio | 11.93 |
| 6.08 | Price to Gross Profit | 3.87 |
| 51.86 | Price to R&D | 26.08 |
| 7.23 | Price to Current Assets | 1.98 |
BDX vs BAX at a glance
Becton Dickinson & CO (BDX) and Baxter International INC (BAX) are both Medical Instruments & Supplies companies in the Healthcare sector. BDX is the larger, at $58.9 billion in market value against $13.5 billion for BAX, about 4.3 times the size.
On trailing-twelve-month figures, BDX trades at 2.8 times trailing sales and BAX at 1.2; net profit margins are 4.5% and -6.2%.